Wolverine Trading, LLC Neurocrine Biosciences Inc Put Options Transaction History

Wolverine Trading, LLC

$97.8 Billion
Q1 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $678,080 - $747,448	5,200 New	5,200 $717,000
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $398,475 - $521,455	5,500 Added 130.95%	9,700 $897,000
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $79,650 - $106,220	1,000 Added 31.25%	4,200 $355,000
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $275,776 - $316,896	-3,200 Reduced 50.0%	3,200 $302,000
Q2 2021 Aug 06, 2021	SELL	$89.43 - $102.27 $357,720 - $409,080	-4,000 Reduced 38.46%	6,400 $620,000

Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $569,205 - $776,100	-6,500 Reduced 38.46%	10,400 $980,000
Q4 2020 Feb 12, 2021	SELL	$86.91 - $108.33 $182,511 - $227,493	-2,100 Reduced 11.05%	16,900 $1.61 Million
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $163,472 - $229,755	1,700 Added 9.83%	19,000 $1.86 Million
Q2 2020 Aug 13, 2020	SELL	$85.09 - $130.36 $680,720 - $1.04 Million	-8,000 Reduced 31.62%	17,300 $2.17 Million
Q1 2020 May 11, 2020	BUY	$75.11 - $113.76 $135,198 - $204,768	1,800 Added 7.66%	25,300 $2.32 Million
Q4 2019 Feb 12, 2020	BUY	$86.8 - $118.57 $2.04 Million - $2.79 Million	23,500 New	23,500 $2.52 Million
Q2 2019 Aug 20, 2019	SELL	$72.24 - $91.27 $3.24 Million - $4.1 Million	-44,900 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $755,479 - $997,677	10,900 Added 32.06%	44,900 $3.96 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $519,231 - $945,136	-7,600 Reduced 18.27%	34,000 $2.33 Million
Q3 2018 Nov 14, 2018	BUY	$98.88 - $125.85 $1.76 Million - $2.24 Million	17,800 Added 74.79%	41,600 $5.12 Million
Q1 2018 May 15, 2018	SELL	$75.88 - $92.43 $7,588 - $9,243	-100 Reduced 0.42%	23,800 $1.97 Million
Q4 2017 Feb 14, 2018	BUY	$58.53 - $77.59 $1.18 Million - $1.57 Million	20,200 Added 545.95%	23,900 $1.85 Million
Q3 2017 Nov 15, 2017	BUY	$47.97 - $61.28 $177,489 - $226,736	3,700	3,700 $227,000

Others Institutions Holding NBIX

# of Institutions

628

Shares Held

94.4M

Call Options Held

505K

Put Options Held

343K

Black Rock Inc. New York, NY

13.8M
Shares

$1.91 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

9.93M
Shares

$1.38 Billion
0.03% of portfolio
State Street Corp Boston, MA

3.99M
Shares

$555 Million
0.02% of portfolio
Jpmorgan Chase & CO New York, NY

2.3M
Shares

$319 Million
0.03% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.25M
Shares

$313 Million
0.49% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.3B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account